Reborna Biosciences
Fujisawa
About Reborna Biosciences
Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients suffering from rare genetic diseases including spinal muscular atrophy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.6M
- Last round: Series Unknown (Jun 2025)
- Website: rebornabiosciences.com
- Phone: +81 466-32-1124
Industries & Categories
B2B, Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/reborna-biosciences-68840 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.